Induction of Cyclooxygenase-2 and Peroxisome Proliferator-Activated Receptor-γ during Nitric Oxide-Induced Apoptotic PC12 Cell Death

Annals of the New York Academy of Sciences

Volumn 1010, Issue , 2003, Pages 648-658

  Lim, S O Young ^a   Jang, Jung Hee ^a   Surh, Young Joon ^a  

^a Seoul National University   (South Korea)

Author keywords

Apoptosis; Cyclooxygenase 2 (COX 2); Nitric oxide; Nitrosative stress; PC12 cells; Peroxisome proliferator activated receptor (PPAR ); Prostaglandin E2

Indexed keywords

APOPTOSIS INDUCING FACTOR; CYCLOOXYGENASE 2; INDUCIBLE NITRIC OXIDE SYNTHASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; NONSTEROID ANTIINFLAMMATORY AGENT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROSTAGLANDIN E2; PROTEIN P21;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; BRAIN MITOCHONDRION; CELL DEATH; CELL DIVISION; CELL PROTECTION; CELL STRAIN; CONFERENCE PAPER; CONTROLLED STUDY; CYTOTOXICITY; ENZYME INDUCTION; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; NEUROLOGIC DISEASE; NEUROPROTECTION; NEUROTOXICITY; NITROSATION; NONHUMAN; ONSET AGE; PROTEIN EXPRESSION; PROTEIN INDUCTION; RAT;

ANIMALIA; RATTUS;

EID: 1342347847     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1299.119     Document Type: Conference Paper

References (35)

1. BREITNER, J.C. 1996. Inflammatory processes and antiinflammatoty drugs in Alzheimer's disease: a current appraisal. Neurobiol. Aging 17: 789-794.
2. MCGEER, E.G. & P.L. MCGEER. 1998. The importance of inflammatory mechanisms in Alzheimer disease. Exp. Gerontol. 33: 371-378.
3. HEALES, S.J., J.P. BOLANOS., V.C. STEWART, et al. 1999. Nitric oxide, mitochondria and neurological disease. Biochim. Biophys. Acta 1410: 215-228.
4. BRUNE, B., C. GOTZ, U.K. MESSMER, et al. 1997. Superoxide formation and macrophage resistance to nitric oxide-mediated apoptosis. J. Biol. Chem. 272: 7253-7258.
5. SZABO, C., B.J. DAY & A.L. SALZMAN. 1996. Evaluation of the relative contribution of nitric oxide and peroxynitrite to the suppression of mitochondrial respiration in immunostimulated macrophages using a manganese mesoporphyrin superoxide dismutase mimetic and peroxynitrite scavenger. FEBS Lett. 381: 82-86.
6. BEAL, M.F. 2002. Oxidatively modified proteins in aging and disease. Free Radic. Biol. Med. 32: 797-803.
7. BROWN, G.C. & V. BORUTAITE. 2001. Nitric oxide, mitochondria, and cell death. IUBMB Life 52: 189-195.
8. WAF1/CIP1. J. Leukoc. Biol. 68: 916-922.
9. WAF1/CIP1 by caspases is an early event during DNA damage-induced apoptosis. J. Biol. Chem. 273: 19207-19212.
10. KITAMURA, Y., S. SHIMOHAMA, H. KOIKE, et al. 1999. Increased expression of cyclooxygenases and peroxisome proliferator activated receptor-gamma in Alzheimer's disease brains. Biochem. Biophys. Res. Commun. 254: 582-586.
11. NOGAWA, S., F. ZHANG, M.E. ROSS, et al. 1997. Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage. J. Neurosci, 17: 2746-2755.
12. MCGEER, E.G. & P.L. MCGEER. 1998. The importance of inflammatory mechanisms in Alzheimer disease. Exp. Gerontol. 33: 371-378.
13. STEWART, W.F., C. KAWAS, M. CORRADA, et al. 1997. Risk of Alzheimer's disease and duration of NSAID use. Neurology 48: 626-632.
14. 2 induces caspase-dependent apoptosis in rat cortical cells. Neurosci. Lett. 317: 61-64.
15. PRASAD, K.N., A.R. HOVLAND, F.G. LA ROSA, et al. 1998. Prostaglandins as putative neurotoxins in Alzheimer's disease. Proc. Soc. Exp. Biol. Med. 219: 120-125.
16. MONTINE, T.J., D. MILATOVIC, R.C. GUPTA, et al. 2002. Neuronal oxidative damage from activated innate immunity is EP2 receptor-dependent. J. Neurochem. 83: 463-470.
17. BEZZI, P., G. CARMIGNOTO, L. PASTI, et al. 1998. Prostaglandins stimulate calcium-dependent glutamate release in astrocytes. Nature 391: 281-285.
18. 2 or cAMP against microglial and neuronal free radical mediated toxicity associated with inflammation. J. Neurosci. Res. 70: 97-107.
19. CAGGIANO, A.O. & R.P. KRAIG. 1999. Prostaglandin E receptor subtypes in cultured rat microglia and their role in reducing lipopolysaccharide-induced interleukin-1beta production. J. Neurochem. 72: 565-575.
20. LEMBERGER, T., O. BRAISSANT, C. JUGE-AUBRY, et al. 1996. PPAR tissue distribution and interactions with other hormone-signaling pathways. Ann. N.Y. Acad. Sci. 804: 231-251.
21. VAMECQ, J. & N. LATRUFFE. 1999. Medical significance of peroxisome proliferator-activated receptors. Lancet 354: 141-148.
22. LEHMANN, J.M., J.M. LENHARD, B.B. OLIVER, et al. 1997. Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs. J. Biol. Chem. 272: 3406-3410.
23. RICOTE, M., A.C. LI, T.M. WILLSON, et al. 1998. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 391: 79-82.
24. KITAMURA, Y., S. SHIMOHAMA, H. KOIKE, et al. 1999. Increased expression of cyclooxygenases and peroxisome proliferator-activated receptor-gamma in Alzheimer's disease brains. Biochem. Biophys. Res. Commun. 254: 582-586.
25. UCHIYAMA, T., H. OTANI, T. OKADA, et al. 2002. Nitric oxide induces caspase-dependent apoptosis and necrosis in neonatal rat cardiomyocytes. J. Mol. Cell. Cardiol. 34: 1049-1061.
26. SUN, Y., X.M. TANG, E. HALF, et al. 2002. Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells. Cancer Res. 62: 6323-6328.
27. TANG, X., Y.J. SUN, E. HALF, et al. 2002. Cyclooxygenase-2 overexpression inhibits death receptor 5 expression and confers resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human colon cancer cells. Cancer Res. 62: 4903-4908.
28. CHANG, Y.W., R. JAKOBI, A. MCGINTY, et al. 2000. Cyclooxygenase 2 promotes cell survival by stimulation of dynein light chain expression and inhibition of neuronal nitric oxide synthase activity. Mol. Cell. Biol. 20: 8571-8579.
29. 2 participate in lipopolysaccharide/interferon-gamma- induced heme oxygenase 1 and prevent RAW264.7 macrophages from UV-irradiation-induced cell death. J. Cell. Biochem. 86: 331-339.
30. 2 protects cultured cortical neurons against N-methyl-D-aspartate receptor-mediated glutamate cytotoxicity. Brain Res. 663: 237-243.
31. 2 via the induction of cyclooxygenase-2. J. Immunol. 165: 3402-3410.
32. BREYER, R.M., C.K. BAGDASSARIAN, S.A. MYERS, et al. 2001. Prostanoid receptors: subtypes and signaling. Annu. Rev. Pharmacol. Toxicol. 41: 661-690.
33. COLVILLE-NASH, P.R. & D.W. GILROY. 2000. COX-2 and the cyclopentenone prostaglandins - a new chapter in the book of inflammation. Prostaglandins Other Lipid Mediat. 62: 33-43.
34. JIANG, C., A.T. TING & B. SEED. 1998. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 391: 82-86.
35. phox and attenuates the respiratory burst. J. Immunol. 169: 2619-2626.